- Home
- ASRT vs WAI Comparison
ASRT vs WAI Comparison
Compare ASRT & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- WAI
- Stock Information
- Founded
- ASRT 1995
- WAI 2018
- Country
- ASRT United States
- WAI China
- Employees
- ASRT N/A
- WAI N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- WAI
- Sector
- ASRT Health Care
- WAI
- Exchange
- ASRT Nasdaq
- WAI NYSE
- Market Cap
- ASRT 85.1M
- WAI 87.8M
- IPO Year
- ASRT 1997
- WAI 2023
- Fundamental
- Price
- ASRT $0.83
- WAI $0.33
- Analyst Decision
- ASRT Strong Buy
- WAI
- Analyst Count
- ASRT 4
- WAI 0
- Target Price
- ASRT $3.19
- WAI N/A
- AVG Volume (30 Days)
- ASRT 634.7K
- WAI 82.4K
- Earning Date
- ASRT 03-10-2025
- WAI 02-21-2025
- Dividend Yield
- ASRT N/A
- WAI N/A
- EPS Growth
- ASRT N/A
- WAI N/A
- EPS
- ASRT N/A
- WAI N/A
- Revenue
- ASRT $125,763,000.00
- WAI $3,989,698.00
- Revenue This Year
- ASRT N/A
- WAI N/A
- Revenue Next Year
- ASRT $1.84
- WAI N/A
- P/E Ratio
- ASRT N/A
- WAI N/A
- Revenue Growth
- ASRT N/A
- WAI N/A
- 52 Week Low
- ASRT $0.73
- WAI $0.19
- 52 Week High
- ASRT $1.80
- WAI $1.75
- Technical
- Relative Strength Index (RSI)
- ASRT 42.81
- WAI N/A
- Support Level
- ASRT $0.78
- WAI N/A
- Resistance Level
- ASRT $0.94
- WAI N/A
- Average True Range (ATR)
- ASRT 0.05
- WAI 0.00
- MACD
- ASRT -0.00
- WAI 0.00
- Stochastic Oscillator
- ASRT 29.56
- WAI 0.00
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).